Neil Gagnon - 30 Jun 2021 Form 4 Insider Report for Apollo Endosurgery, Inc.

Role: 10%+ Owner
Signature: /s/ Neil Gagnon
Issuer symbol: N/A
Transactions as of: 30 Jun 2021
Net transactions value: $0
Form type: 4
Filing time: 08 Jul 2021, 12:18:47 UTC
Previous filing: 15 Jun 2021
Next filing: 04 Oct 2021
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	APEN	Common Stock, $0.001 par value per share	Other	$0	+3,337	+0.81%	$0.000000	413,962	30 Jun 2021	Direct	F2
transaction	APEN	Common Stock, $0.001 par value per share	Other	$0	+1,001	+1.2%	$0.000000	85,015	30 Jun 2021	By Limited Partner of the Family Partnership	F2
holding	APEN	Common Stock, $0.001 par value per share						1,329,354	30 Jun 2021	By Managing Member as General Partner of Gagnon Investment Associates	F1
holding	APEN	Common Stock, $0.001 par value per share						116,360	30 Jun 2021	By Managing Member as General Partner of Darwin Partnership	F1
holding	APEN	Common Stock, $0.001 par value per share						26,446	30 Jun 2021	By self as Trustee of Gagnon Securities LLC Profit Sharing Plan	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Neil Gagnon serves as the Chief Executive Officer of Gagnon Advisors, LLC and is the managing member and principal owner of Gagnon Securities LLC, each of which provide investment management services to investment vehicles and managed accounts (collectively, the "Accounts"), and as such, has investment discretion with respect to the Accounts. Mr. Gagnon's interest in the securities reported herein is limited to the extent of his pecuniary interest in each of the Accounts, if any.
F2	The shares of common stock were received as an in-kind quarterly interest payment with respect to the 6.0% Convertible Debentures due 2024 (the "Debentures") held by the Darwin Partnership. The Debentures will mature on August 12, 2024 unless earlier converted or repurchased in accordance with their terms. The Debentures are convertible, at the option of the holders, into shares of common stock at an initial conversion price of $3.25 per share, subject to adjustment. If the VWAP of the Issuer's common stock has been at least $9.75 (subject to adjustment) for at least 20 trading days during any 30 consecutive trading day period, the Issuer may force the conversion of all or any part of the outstanding principal amount of the Debentures, accrued and unpaid interest and any other amounts then owing, subject to certain conditions.

Content

Neil Gagnon serves as the Chief Executive Officer of Gagnon Advisors, LLC and is the managing member and principal owner of Gagnon Securities LLC, each of which provide investment management services to investment vehicles and managed accounts (collectively, the "Accounts"), and as such, has investment discretion with respect to the Accounts. Mr. Gagnon's interest in the securities reported herein is limited to the extent of his pecuniary interest in each of the Accounts, if any.

The shares of common stock were received as an in-kind quarterly interest payment with respect to the 6.0% Convertible Debentures due 2024 (the "Debentures") held by the Darwin Partnership. The Debentures will mature on August 12, 2024 unless earlier converted or repurchased in accordance with their terms. The Debentures are convertible, at the option of the holders, into shares of common stock at an initial conversion price of $3.25 per share, subject to adjustment. If the VWAP of the Issuer's common stock has been at least $9.75 (subject to adjustment) for at least 20 trading days during any 30 consecutive trading day period, the Issuer may force the conversion of all or any part of the outstanding principal amount of the Debentures, accrued and unpaid interest and any other amounts then owing, subject to certain conditions.